| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8650962 | American Heart Journal | 2018 | 29 Pages |
Abstract
The use of rivaroxaban compared with warfarin was associated with a higher risk of stroke and bleeding in patients with polyvascular disease enrolled in ROCKET AF. Further studies are needed to understand the optimal management of this high-risk population.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sean T. BS, Anne S. MS, Richard C. MD, Scott D. MD, Günter MD, Keith A.A. MB, ChB, Werner MD, Jonathan L. MD, Graeme J. MD, Kenneth W. MD, Christopher C. MD, Jonathan P. MD, MHS, Daniel E. MD, Manesh R. MD,